In silico design of a novel hybrid epitope-based antigen harboring highly exposed immunogenic peptides of BamA, OmpA, and Omp34 against Acinetobacter baumannii
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.113066 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Anahita Hessami und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Bacterial Outer Membrane Proteins, Antigens, Bacterial, Epitopes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 126 Literaturangaben.
Abstract (Originalsprache)
Acinetobacter baumannii, is among the highest priority bacteria according to the WHO categorization which necessitate the exploration of alternative strategies such as vaccination. OmpA, BamA, and Omp34 are assigned as appropriate antigens to serve in vaccine development against this pathogen. Experimentally validated exposed epitopes of OmpA and Omp34 along with selected exposed epitopes predicted by an integrative in silico approach were represented by the barrel domain of BamA as a scaffold. Among the 8 external loops of BamA, 5 loops were replaced with selected loops of OmpA and Omp34. The designed antigen was analyzed regarding the physicochemical properties, antigenicity, epitope retrieval, topology, structure, and safety. BamA is a two-domain OMP with a 16-stranded barrel in which L4, L6, and L7 were the longest loops of BamA in order. The designed antigen consisted of 478 amino acids with antigen probability of 0.7793. The novel antigen was a 16-stranded barrel. No identical 8-meric peptides were found in the human proteome against the designed antigen sequence. The designed construct was safe regarding the allergenicity, toxicity, and human proteome reactivity. The designed antigen could develop higher protection against A. baumannii in comparison to either OmpA, BamA, or Omp34 alone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
- Faculty of Agriculture, Shahed University, Tehran, Iran.
- Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares, P.O. Box: 14115-154, Tehran, Iran.
- Department of Research and Production of Poultry Viral Vaccine, Razi Vaccine and Serum Research Institute, Agricultural Research Education and Extension Organization, Karaj, Iran.
- College of Veterinary Medicine, Sulaimani University, Kurdistan Region, Iraq.
- Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Zitieren
APA
Hessami, A., Mogharari, Z., Rahim, F., Khalesi, B., Jamal Nassrullah, O., Reza Rahbar, M., Khalili, S., & Jahangiri, A. (2024). In silico design of a novel hybrid epitope-based antigen harboring highly exposed immunogenic peptides of BamA, OmpA, and Omp34 against Acinetobacter baumannii. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113066
Vancouver
Hessami A, Mogharari Z, Rahim F, Khalesi B, Jamal Nassrullah O, Reza Rahbar M, et al. In silico design of a novel hybrid epitope-based antigen harboring highly exposed immunogenic peptides of BamA, OmpA, and Omp34 against Acinetobacter baumannii. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.113066
BibTeX
@article{Hessami2024,
author = {Hessami, Anahita and Mogharari, Zahra and Rahim, Fatemeh and Khalesi, Bahman and Jamal Nassrullah, Othman and Reza Rahbar, Mohammad and Khalili, Saeed and Jahangiri, Abolfazl},
title = {In silico design of a novel hybrid epitope-based antigen harboring highly exposed immunogenic peptides of BamA, OmpA, and Omp34 against Acinetobacter baumannii},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.113066}
}
EUVIMED